Idelalisib
Drug timelines are a Plus or Pro feature.
37 regulatory and trial events tracked for Idelalisib, covering 2014-01-06 to 2025-03-07. Get the full timeline:
Most recent: Clinical Trial Update: Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) [Phase 3]